Intralipid: Difference between revisions
(Created page with "==General== *Type: *Dosage Forms: *Routes of Administration: *Common Trade Names: ==Adult Dosing== ==Pediatric Dosing== ==Special Populations== *Drug Ratings in Pregnan...") |
|||
| (33 intermediate revisions by 10 users not shown) | |||
| Line 1: | Line 1: | ||
==General== | ==General== | ||
*Type: | *Type: Lipid emulsion therapy | ||
*Dosage Forms: | *Dosage Forms: 10%, 20%, and 30% lipid emulsions | ||
*Routes of Administration: | **Note that 20% is used for lipid rescue therapy for systemic drug toxicity<ref>http://www.lipidrescue.org/</ref> | ||
*Common Trade Names: | *Routes of Administration: IV | ||
*Common Trade Names: Intralipid, Lipid Rescue <ref>http://www.lipidrescue.org/</ref> | |||
==Adult Dosing== | ==Adult Dosing== | ||
Note that dosing for adults and children is not standardized but is based on case reports and recommendations<ref>http://www.lipidrescue.org/</ref> | |||
*1.5 mL/kg bolus over 1 minute<ref>Cave, G. Intravenous Lipid Emulsion as Antidote Beyond Local Anesthetic Toxicity: A Systematic Review. 2009. 16(9)815–824</ref><ref>https://canadiem.org/iv-lipid-emulsion-for-drug-toxicity-in-the-ed/</ref> | |||
**Note that dosing is based on lean or ideal body mass<ref>https://canadiem.org/iv-lipid-emulsion-for-drug-toxicity-in-the-ed/</ref> | |||
**Followed by 0.25 mL/kg/min for 20 min or until hemodynamic stability is achieved.<ref>Dillane D, Finucane BT. Local anesthetic systemic toxicity. Can J Anaesth. 2010 Apr;57(4):368-80.</ref> | |||
===Persistent Cardiovascular Collapse=== | |||
*May repeat bolus once or twice for persistent cardiovascular collapse<ref>http://www.lipidrescue.org/</ref> | |||
*May double rate of infusion to 0.5 mL/kg/min for persistent hypotension<ref>http://www.lipidrescue.org/</ref> | |||
*Max cumulative dose: 12 ml/kg | |||
===After Cardiovascular Stability Achieved=== | |||
*Maintain infusion for at least 10 minutes<ref>http://www.lipidrescue.org/</ref> | |||
===Simplified Protocol<ref>https://canadiem.org/iv-lipid-emulsion-for-drug-toxicity-in-the-ed/</ref>=== | |||
*Based on 'average' 70 kg patient | |||
**100 mL IV bolus over 1 minute | |||
**Infusion at 18 mL/h IV | |||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
As with adults, pediatric dosing is not standardized<ref>http://www.lipidrescue.org/</ref> | |||
*Initial bolus of 0.8 - 3 mL/kg<ref>Lipid emulsion (conventional, soybean oil-based): Drug information. Uptodate. Accessed May 15 2019.</ref> | |||
*No recommendations provided for rate of ongoing infusion | |||
==Special Populations== | ==Special Populations== | ||
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: | *[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C | ||
*[[Lactation risk categories|Lactation risk]]: | *[[Lactation risk categories|Lactation risk]]: | ||
*Renal Dosing | *Renal Dosing | ||
| Line 18: | Line 42: | ||
**Adult | **Adult | ||
**Pediatric | **Pediatric | ||
==Emergency department indications<ref>http://www.lipidrescue.org/</ref><ref>https://canadiem.org/iv-lipid-emulsion-for-drug-toxicity-in-the-ed/</ref>== | |||
*Severe systemic drug toxicity plus: | |||
**Persistent hemodynamic instability | |||
**All conventional options have been exhausted | |||
**Toxicity has poor prognosis | |||
*Common toxicities | |||
**[[Local anesthetic systemic toxicity]] | |||
**[[Beta blocker]] | |||
**[[Calcium Channel Blocker]] | |||
**[[TCA]] | |||
**[[Bupropion]] | |||
==Contraindications== | ==Contraindications== | ||
| Line 24: | Line 60: | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
===Serious=== | ===Serious=== | ||
*Asystole (case reported) <ref>Cole JB et al. Asystole immediately following intravenous fat emulsion for overdose. J Med Toxicol. 2014;10(3)307-310</ref> | |||
*Fat embolism | |||
*Hypersensitivity reactions | |||
*ARDS | |||
===Common=== | ===Common=== | ||
*[[Pancreatitis]]<ref name = review> Kostic MA and Gorelick M. Review of the use of lipid emulsion in nonlocal anesthetic poisoning. Pediatric Emergency Care 2014;30:427-436</ref> | |||
*Hypertriglyceridemia<ref name=review></ref> | |||
*Interferes with some lab measurements | |||
**Glucose and magnesium concentrations become inaccurate | |||
**Creatinine and lipase become unmeasurable | |||
==Pharmacology== | ==Pharmacology== | ||
| Line 32: | Line 77: | ||
*Excretion: | *Excretion: | ||
*Mechanism of Action: | *Mechanism of Action: | ||
**Unclear, but proposed mechanisms include<ref>https://canadiem.org/iv-lipid-emulsion-for-drug-toxicity-in-the-ed/</ref>: | |||
***Lipid sink/partition | |||
****Emulsion surrounds lipophilic drug molecule, partitioning it from target organs | |||
***Cardiac metabolism | |||
****Fatty acids provide the myocardium with a ready energy source, improving cardiac contractility | |||
==Comments== | ==Comments== | ||
*Avoid co-administration of:<ref>http://www.lipidrescue.org/</ref> | |||
**[[Vasopressin]] | |||
**[[Calcium channel blockers]] | |||
**[[Beta-blockers]] | |||
**[[Local anesthetics]] | |||
**High-dose [[epinephrine]] | |||
**[[Propofol]] | |||
==See Also== | ==See Also== | ||
*[[Beta-blocker toxicity]] | |||
*[[Calcium channel blocker toxicity]] | |||
*[[Local Anesthetic Systemic Toxicity (LAST)]] | |||
*[[Tricyclic antidepressant toxicity]] | |||
==External Links== | |||
*[http://www.lipidrescue.org/ LipidRescue] | |||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category: | [[Category:Pharmacology]] | ||
[[Category: | [[Category:Toxicology]] | ||
Latest revision as of 20:18, 17 April 2024
General
- Type: Lipid emulsion therapy
- Dosage Forms: 10%, 20%, and 30% lipid emulsions
- Note that 20% is used for lipid rescue therapy for systemic drug toxicity[1]
- Routes of Administration: IV
- Common Trade Names: Intralipid, Lipid Rescue [2]
Adult Dosing
Note that dosing for adults and children is not standardized but is based on case reports and recommendations[3]
Persistent Cardiovascular Collapse
- May repeat bolus once or twice for persistent cardiovascular collapse[8]
- May double rate of infusion to 0.5 mL/kg/min for persistent hypotension[9]
- Max cumulative dose: 12 ml/kg
After Cardiovascular Stability Achieved
- Maintain infusion for at least 10 minutes[10]
Simplified Protocol[11]
- Based on 'average' 70 kg patient
- 100 mL IV bolus over 1 minute
- Infusion at 18 mL/h IV
Pediatric Dosing
As with adults, pediatric dosing is not standardized[12]
- Initial bolus of 0.8 - 3 mL/kg[13]
- No recommendations provided for rate of ongoing infusion
Special Populations
- Pregnancy Rating: C
- Lactation risk:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Emergency department indications[14][15]
- Severe systemic drug toxicity plus:
- Persistent hemodynamic instability
- All conventional options have been exhausted
- Toxicity has poor prognosis
- Common toxicities
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
- Asystole (case reported) [16]
- Fat embolism
- Hypersensitivity reactions
- ARDS
Common
- Pancreatitis[17]
- Hypertriglyceridemia[17]
- Interferes with some lab measurements
- Glucose and magnesium concentrations become inaccurate
- Creatinine and lipase become unmeasurable
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
- Unclear, but proposed mechanisms include[18]:
- Lipid sink/partition
- Emulsion surrounds lipophilic drug molecule, partitioning it from target organs
- Cardiac metabolism
- Fatty acids provide the myocardium with a ready energy source, improving cardiac contractility
- Lipid sink/partition
- Unclear, but proposed mechanisms include[18]:
Comments
- Avoid co-administration of:[19]
See Also
- Beta-blocker toxicity
- Calcium channel blocker toxicity
- Local Anesthetic Systemic Toxicity (LAST)
- Tricyclic antidepressant toxicity
External Links
References
- ↑ http://www.lipidrescue.org/
- ↑ http://www.lipidrescue.org/
- ↑ http://www.lipidrescue.org/
- ↑ Cave, G. Intravenous Lipid Emulsion as Antidote Beyond Local Anesthetic Toxicity: A Systematic Review. 2009. 16(9)815–824
- ↑ https://canadiem.org/iv-lipid-emulsion-for-drug-toxicity-in-the-ed/
- ↑ https://canadiem.org/iv-lipid-emulsion-for-drug-toxicity-in-the-ed/
- ↑ Dillane D, Finucane BT. Local anesthetic systemic toxicity. Can J Anaesth. 2010 Apr;57(4):368-80.
- ↑ http://www.lipidrescue.org/
- ↑ http://www.lipidrescue.org/
- ↑ http://www.lipidrescue.org/
- ↑ https://canadiem.org/iv-lipid-emulsion-for-drug-toxicity-in-the-ed/
- ↑ http://www.lipidrescue.org/
- ↑ Lipid emulsion (conventional, soybean oil-based): Drug information. Uptodate. Accessed May 15 2019.
- ↑ http://www.lipidrescue.org/
- ↑ https://canadiem.org/iv-lipid-emulsion-for-drug-toxicity-in-the-ed/
- ↑ Cole JB et al. Asystole immediately following intravenous fat emulsion for overdose. J Med Toxicol. 2014;10(3)307-310
- ↑ 17.0 17.1 Kostic MA and Gorelick M. Review of the use of lipid emulsion in nonlocal anesthetic poisoning. Pediatric Emergency Care 2014;30:427-436
- ↑ https://canadiem.org/iv-lipid-emulsion-for-drug-toxicity-in-the-ed/
- ↑ http://www.lipidrescue.org/
